Innovative solutions to novel drug development in mental health

Summary & key facts

This review says that new tools in brain science could help us understand mental illnesses better and lead to earlier, more effective treatments. The authors argue that combining different biological signs—like genes, brain scans, and thinking tests—can guide both drug and non-drug treatment research. They also say we need better training for doctors who do research and more cooperation between universities and industry to turn ideas into real treatments that improve thinking, daily functioning, and well-being.

Key facts:

• The paper argues that recent advances in neuroscience could help explain the brain problems behind various mental illnesses and point to new treatments.
• The authors recommend a biomarker approach, which means using measurable biological signs such as genetics, brain scans, and cognitive tests together to understand and test treatments.
• They describe both drug and non-drug strategies as important areas for new treatment development, and they highlight several novel biological mechanisms that already have early clinical support.
• The review stresses the value of translation and back-translation, which means moving ideas from the lab into patient studies and then using patient results to refine lab research.
• The authors call for new training for clinician-scientists—doctors who do research—so they learn the experimental and conceptual tools needed for this work.
• They also emphasize the need for public-private partnerships and sharing knowledge before commercial competition, to speed up development of useful treatments.
• The overall goal described is to create holistic treatments that help thinking ability, everyday functioning, and the general well-being of people with neuropsychiatric disorders.

Abstract

There are many new advances in neuroscience and mental health which should lead to a greater understanding of the neurobiological dysfunction in neuropsychiatric disorders and new developments for early, effective treatments. To do this, a biomarker approach combining genetic, neuroimaging, cognitive and other biological measures is needed. The aim of this article is to highlight novel approaches for pharmacological and non-pharmacological treatment development. This article suggests approaches that can be taken in the future including novel mechanisms with preliminary clinical validation to provide a toolbox for mechanistic studies and also examples of translation and back-translation. The review also emphasizes the need for clinician-scientists to be trained in a novel way in order to equip them with the conceptual and experimental techniques required, and emphasizes the need for private-public partnership and pre-competitive knowledge exchange. This should lead the way for important new holistic treatment developments to improve cognition, functional outcome and well-being of people with neuropsychiatric disorders.

Topics

Functional Brain Connectivity Studies Treatment of Major Depression Tryptophan and brain disorders

Categories

Health Sciences Medicine Pharmacology

Tags

Cognition Computer science Drug Drug development Economics Finance General partnership Mental health Neuroimaging Neuroscience Programming language Psychiatry Psychology Psychotherapist Toolbox

Conditions & symptoms

Anxiety Depression PTSD